1-Hydroxybenzotriazole → (E)-3-[5-(1H-imidazol-1-yl)-6-methoxypyridin-2-yl]-N-[2-oxo-3-(2-trifluoromethylphenyl)piperidin-1-yl]acrylamide
반응식
C(N(C(C)C)CC)(C)C.C1C=CC2N(O)N=NC=2C=1.[NH2:20][N:21]1[CH2:26][CH2:25][CH2:24][CH:23]([C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=2[C:33]([F:36])([F:35])[F:34])[C:22]1=[O:37].[N:38]1([C:43]2[CH:44]=[CH:45][C:46](/[CH:51]=[CH:52]/[C:53](O)=[O:54])=[N:47][C:48]=2[O:49][CH3:50])[CH:42]=[CH:41][N:40]=[CH:39]1.C(=O)(O)[O-].[Na+]>CN(C=O)C.C(Cl)CCl>[N:38]1([C:43]2[CH:44]=[CH:45][C:46](/[CH:51]=[CH:52]/[C:53]([NH:20][N:21]3[CH2:26][CH2:25][CH2:24][CH:23]([C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=4[C:33]([F:34])([F:35])[F:36])[C:22]3=[O:37])=[O:54])=[N:47][C:48]=2[O:49][CH3:50])[CH:42]=[CH:41][N:40]=[CH:39]1참가 물질
8
반응물 5
생성물 1
시약·촉매·용매 2
실험 절차
IPEA (742 μL), EDC (206 mg) and HOBT (146 mg) were added to a mixture of 1-amino-3-(2-trifluoromethylphenyl)piperidin-2-one (185 mg), (E)-3-[5-(1H-imidazol-1-yl)-6-methoxypyridin-2-yl]acrylic acid (340 mg) and DMF (5 mL), and the reaction solution was stirred at room temperature for 14 hours. A saturated sodium bicarbonate solution was added to the reaction solution, followed by extraction with ethyl acetate. The organic layer was dried over magnesium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (carrier: Chromatorex NH; elution solvent: ethyl acetate→ethyl acetate:methanol=9:1) to obtain the title compound (453 mg). The property value of the compound is as follows.
후처리
- extractionfollowed by extraction with ethyl acetate
- dry with materialThe organic layer was dried over magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified by silica gel chromatography (carrier: Chromatorex NH; elution solvent: ethyl acetate→ethyl acetate:methanol=9:1)
출처 및 근거
- ORD 기록
- ord-231f77c77e6240b8ad966c4e0fcb90c4
- 출처 데이터셋
- uspto-grants-2011_05
- 특허 번호
- US07935815B2
반응 노트
불러오는 중…